02 Oct 2017
5-10% of hypothyroid patients on T4 replacement have persistent symptoms, despite normal TSH levels. T4+T3 combination therapy provided no better outcomes according to a meta-analysis of 11 randomized clinical trials comparing T4 monotherapy with T4+T3 combination therapy. A review in EJE evaluates recent developments in the field of T4+T3 therapy.
Read the full article here.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024